Question · QUESTION_WRITTEN
E-9-2020-005835
Premature deaths of cancer patients due to slow authorisation of new anti-cancer drugs in the EU as compared with the United States
Original: Voortijdig overlijden van kankerpatiënten door de trage toelating van nieuwe medicijnen tegen kanker in EU in vergelijking met de Verenigde Staten
Official English title
Introduced
27 October 2020
Last action
26 January 2021 · Answer
Status
answered
Sponsors
—
Subjects
Discovery layer
Source updated
26 January 2021
Official titles
Authentic titles published by the source. The stored canonical title is not replaced.
1 official language
- English
Premature deaths of cancer patients due to slow authorisation of new anti-cancer drugs in the EU as compared with the United States
Timeline
27 October 2020
Written question
Voortijdig overlijden van kankerpatiënten door de trage toelating van nieuwe medicijnen tegen kanker in EU in vergelijking met de Verenigde Staten
Source: QUESTION_WRITTEN
26 January 2021
Answer
Source: QUESTION_WRITTEN_ANSWER
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
7 official files
Premature deaths of cancer patients due to slow authorisation of new anti-cancer drugs in the EU as compared with the United States
QUESTION_WRITTEN · EN · 16 November 2020
Premature deaths of cancer patients due to slow authorisation of new anti-cancer drugs in the EU as compared with the United States
QUESTION_WRITTEN · EN · 16 November 2020
Premature deaths of cancer patients due to slow authorisation of new anti-cancer drugs in the EU as compared with the United States
QUESTION_WRITTEN · EN · 16 November 2020
Answer
QUESTION_WRITTEN_ANSWER · 26 January 2021
Voortijdig overlijden van kankerpatiënten door de trage toelating van nieuwe medicijnen tegen kanker in EU in vergelijking met de Verenigde Staten
QUESTION_WRITTEN · NL · 16 November 2020
Voortijdig overlijden van kankerpatiënten door de trage toelating van nieuwe medicijnen tegen kanker in EU in vergelijking met de Verenigde Staten
QUESTION_WRITTEN · NL · 16 November 2020
Voortijdig overlijden van kankerpatiënten door de trage toelating van nieuwe medicijnen tegen kanker in EU in vergelijking met de Verenigde Staten
QUESTION_WRITTEN · NL · 16 November 2020
Sponsors
- Antonius MANDERS · OTHER
- · EU_COMMISSION · ADDRESSEE
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.europarl.europa.eu/doceo/document/E-9-2020-005835_EN.html
- Open data entity: https://data.europarl.europa.eu/api/v2/parliamentary-questions/E-9-2020-005835
- eu · E-9-2020-005835 · source updated 26 January 2021